Biobank study for people at high risk of pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study collects and stores samples (bio-specimens) from adults who have pancreas cysts and are at higher risk for pancreatic cancer. The goal is to help researchers improve early detection so future patients may be diagnosed sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a pancreas cyst
- You must be considered high risk for pancreatic cancer
- You must be able and willing to give consent
- You must be willing to provide bio-specimens (samples)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how medical images and lab samples can predict which pancreatic cysts or tumors are more likely to be dangerous. If you are being evaluated for a pancreatic problem and haven’t started pancreas treatment, your scans and samples may help researchers improve risk prediction.
This study collects blood and cystic fluid samples from people who are already scheduled for surgery to remove a worrisome pancreatic cyst. The goal is to learn more about these cysts and possibly improve future diagnosis and treatment.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This trial collects pancreatic cyst fluid or tissue to study the genes of these tumors. The goal is to better understand pancreatic cysts and improve future treatments.
This study is a registry for people at high risk for pancreatic cancer. Researchers will collect information over time to learn more about how to detect and prevent the disease.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
Hear when a new Pancreatic Cyst trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.